CTRI/2021/02/031430已完成未知
Efficacy of Remdesevir and Hydroxychloroquine in moderate to severe COVID-19 patients admitted in the CCU of a tertiary care hospital in WestBengal,India.
I0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •COVID RTPCR POSITIVE CASES
- •PNEUNONITIS AS EFIDENT FROM CXR, HRCT THORAX
- •REQUIRING OXYGEN VIA NRBM OR HIGHER SUPPORT LIKE HFNO,NIV OR INVASIVE VENTILATIO
排除标准
- •H/O DRUG ALLERGY TO ANY OF THE STUDY DRUGS
- •H/O ADVERSE DRUG REACTION TO ANY OF THE STUDY DRUGS
- •ELEVATED LIVER ENZYMES
- •H/O OCCULAR DISEASE
- •H/O CARDIO VASCULAR CONDUCTION DISEASE
研究者
相似试验
尚未招募
2 期
A clinical Trial to Study the Effects of Hydroxychloroquine, Ciclesonide and Ivermectin in treatment of moderate COVID-19 illnessCTRI/2020/04/024948ady Hardinge Medical College
招募中
3 期
Efficacy of Remdesivir in Comparison with Interferon Beta-1 a and Remdesivir in the Treatment of Covid 19IRCT20200721048159N4Vice Chancellor for Research and Technology of Lorestan University of Medical Sciences100
招募中
3 期
Efficacy of tenofovir in covid-19IRCT20200421047155N1Ardabil University of Medical Sciences86
已完成
3 期
Efficacy and Safety of Hydroxychloroquine and Methotrexate Combination in Treatment of Juvenile Rheumatoid ArthritisCTRI/2011/05/001734Ipca Laboratories Ltd Mumbai77
进行中（未招募）
1 期
Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on Survival in Elderly Hospitalized Patients with VIDOC-19 : A Randomized, Multi-Centre, Adaptive, Blinded StudyEUCTR2020-001303-16-FRHôpitaux Universitaires de Strasbourg1,600